FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
CNN2 天
There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
An authorized generic is different from a generic drug, according to the FDA, because it’s the “exact same drug product” as a branded drug, just without the brand name on the label. A ...
FDA approves GLP-1 generic for Type 2 diabetes
The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who ...
Reuters3 天
US FDA approves Hikma's generic version of Novo's diabetes drug Victoza
It has been on the FDA's shortage list since 2023, and currently remains in tight supply. The agency said it prioritizes review of generic versions of drugs that are in shortage. Victoza is a once ...
MedPage Today2 天
First Generic of Once-Daily GLP-1 Injection Approved for Diabetes
The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...
Chinese Aspirin Costing Under a Cent Shuts Out Foreign Firms
China’s aggressive drive to replace brand-name foreign drugs with dirt-cheap homegrown generics has already taken a toll on ...
The FDA says the shortage of popular weight loss drug Zepbound is over. Here's what that ...
The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...